Ethicon TVT-Secur Mesh Lawsuits Ends in $20 Jury Verdict Against Johnson & Johnson

A state court jury in Philadelphia has returned a $20 million verdict against Johnson & Johnson’s Ethicon division, including punitive damages designed to punish the manufacturer over problems with the Ethicon TVT-Secur transvaginal mesh

The trial involved a lawsuit brought by Margaret Engleman, who received the mesh implant for treatment of stress urinary incontinence, but later developed severe and debilitating complications when the TVT-Secur mesh eroded through her internal flesh. Due to the design of the vaginal mesh, some of it had to be left in Engleman’s body, which has caused ongoing pain and urinary problems.

Late last week, the jury returned a verdict that included $2.5 million in compensatory damages, and an additional $17.5 million punitive damages awarded against the manufacturer for recklessly endangering Engleman and other women.

Learn More About

Vaginal Mesh Lawsuits

Complications from transvaginal mesh may cause severe injuries.

Learn More SEE IF YOU QUALIFY FOR COMPENSATION

Ethicon and other transvaginal mesh manufacturers have faced tens of thousands of similar claims brought by women throughout the United States, each involving allegations that the mesh used for repair of pelvic organ prolapse and female stress urinary incontinence migrated through the vagina, causing infections and other painful injuries. However, many of the manufacturers have reached vaginal mesh settlements to avoid potential jury verdicts.

This case is at least the third multi-million dollar verdict in an Ethicon vaginal mesh lawsuit trial held in the Philadelphia Court of Common Pleas. In February 2016, a jury awarded a woman $13.5 million, including $10 million in punitive damages. That followed a December 2015 trial, which resulted in a $12.5 million award for the plaintiff, including $7 million in punitive damages.

Three additional Ethicon mesh trials are scheduled over the next two months, and the manufacturer has indicated that it intends to appeal last week’s verdict.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted today)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.

Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto
Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto (Posted today)

Bayer and Monsanto prevailed in a Roundup lawsuit that went to trial in Philadelphia this week, after a jury found that exposure to the herbicide did not cause a man to develop non-Hodgkin's lymphoma.

Family Seeks Remand of Bard Hernia Mesh Wrongful Death Lawsuit, After Global Settlement Negotiations “Have Dragged”
Family Seeks Remand of Bard Hernia Mesh Wrongful Death Lawsuit, After Global Settlement Negotiations “Have Dragged” (Posted yesterday)

The Bard hernia mesh lawsuit has been pending for years in the federal MDL, where family indicates global settlement negotiations have stalled, leading to a request to allow their claim to be remanded for trial.